Mister Spex (MRX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
FY2025 marked a structural transformation, focusing on quality of revenue and margin expansion, with intentional revenue decline due to exit from unprofitable international markets and discount reduction.
Gross margin expanded by 580 basis points year-over-year to 55.6%, reflecting a shift to higher-margin products and services.
EBIT loss narrowed by EUR 59 million to EUR -26 million, the largest year-over-year earnings improvement in company history.
Profitable stores increased to 45 of 65, up from 24 last year, reflecting successful store network optimization.
The company completed its multi-year transformation program, laying the foundation for scalable, profitable growth in 2026.
Financial highlights
Net revenue was EUR 181 million, down 16% year-over-year, in line with guidance, driven by strategic international exits and discount reduction.
Gross profit reached EUR 100.9 million, with gross margin up from 49.8% to 55.6%.
EBIT margin improved to -14.5%, within guidance, with EBIT loss narrowed to EUR -26.3 million.
Adjusted EBITDA improved by EUR 22 million within one year, surpassing the two-year target.
Cash and cash equivalents at year-end were EUR 56 million, with a EUR 14.3 million decrease, EUR 37 million better than FY2024.
Outlook and guidance
FY2026 net revenue expected to be flat to -10% versus FY2025, reflecting final normalization after discount detox and international webshop closures.
Adjusted EBITDA margin guided to break even to mid-single digit percent, up from 1.7% in 2025.
Year-end cash expected at EUR 25–30 million, including EUR 4 million for acquisitions and EUR 10–15 million in non-recurring costs.
Latest events from Mister Spex
- Gross margin rose to 48.8% as restructuring drove losses and international sales fell 17%.MRX
Q3 202414 Jan 2026 - Restructuring led to a 3% revenue drop and wider losses in 2024; EBIT to improve in 2025.MRX
H2 202426 Dec 2025 - Gross margin rose to 56.4% and EBIT loss narrowed, despite a 13% revenue drop.MRX
Q1 202523 Dec 2025 - Gross margin rose to 55.0% as cost discipline offset revenue declines and losses narrowed.MRX
Q2 202523 Nov 2025 - Q3 2025 revenue fell 18%, but gross margin and EBIT improved sharply amid ongoing transformation.MRX
Q3 202513 Nov 2025 - Profitability challenges prompt transformation and rebranding amid modest revenue growth.MRX
H1 202413 Jun 2025